Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 3, 2024 - Prasco launched an authorized brand alternative of AstraZeneca’s Xigduo XR (dapagliflozin/metformin) extended-release tablets.
Download PDF
Return to publications
